Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Investigative Dermatology|April 19, 2013
Evidence of a limited intra-individual diversity of nevi: intuitive perception of dominant clusters is a crucial step in the analysis of nevi by dermatologistsYanal Wazaefi, Caroline Gaudy-Marqueste, Marie-Françoise Avril, et al.
Cancers|December 11, 2022
Adrenomedullin Secreted by Melanoma Cells Promotes Melanoma Tumor Growth through Angiogenesis and LymphangiogenesisZohra Benyahia, Caroline Gaudy-Marqueste, Caroline Berenguer-Daizé, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2018
Diabetes and Blood Glucose Disorders Under Anti-PD1Quentin Magis, Caroline Gaudy-Marqueste, Agnes Basire, et al.
Oncoimmunology|November 20, 2019
HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanomaNausicaa Malissen, Nicolas Macagno, Samuel Granjeaud, et al.
Journal of Cancer Research and Clinical Oncology|August 12, 2022
Anti-PD-1 for the treatment of advanced cutaneous squamous cell carcinoma in elderly patients: a French multicenter retrospective surveyQuentin Samaran, Romain Samaran, Ernestine Ferreira, et al.
Journal of the American Academy of Dermatology|July 19, 2021
Molecular characterization of fast-growing melanomasCaroline Gaudy-Marqueste, Nicolas Macagno, Anderson Loundou, et al.
Journal for Immunotherapy of Cancer|August 12, 2025
Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201)Giovanni Grignani, Piotr Rutkowski, Céleste Lebbé, et al.
Nature Medicine|December 5, 2018
Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanomaLucas D Trucco, Piyushkumar A Mundra, Kate Hogan, et al.
Nature Medicine|December 19, 2018
Publisher Correction: Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanomaLucas D Trucco, Piyushkumar A Mundra, Kate Hogan, et al.
Pageof 7